SCHEMBL6601808

SCHEMBL6601808

CCOc1ccc(C(=O)Nc2ccc3c(c2Br)CNCC3)cc1C(C)=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CREBBP Q92793 5/20 0.47
HDAC8 Q9BY41 6/20 0.45
HDAC1 Q13547 5/20 0.45
HDAC6 Q9UBN7 5/20 0.45
MAPT P10636 3/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
TP53 P04637 2/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
ALOX15 P16050 1/20 0.41
ALOX12 P18054 1/20 0.41
NR4A1 P22736 1/20 0.41
HSD17B10 Q99714 1/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
MITF O75030 1/20 0.40
ROCK2 O75116 2/20 0.40
PRKG1 Q13976 1/20 0.40
AKR1C2 P52895 1/20 0.39
AKR1C1 Q04828 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6600619 0.90 CREBBP (0.46) CREBBPHDAC8HDAC1HDAC6MAPT
SCHEMBL5874089 0.83 MAPT (0.46) CREBBPHDAC8HDAC1HDAC6MAPT
SCHEMBL5874058 0.81 HDAC8 (0.48) CREBBPHDAC8HDAC1HDAC6MAPT
SCHEMBL6602268 0.81 MAPT (0.49) HDAC8HDAC1HDAC6MAPTMEN1
SCHEMBL5874128 0.79 MEN1 (0.48) CREBBPHDAC8HDAC1HDAC6MAPT
SCHEMBL6604412 0.79 NPC1 (0.52) HDAC8HDAC1HDAC6MAPTMEN1
SCHEMBL6602358 0.78 CREBBP (0.43) CREBBPHDAC8HDAC1HDAC6MAPT
SCHEMBL6601449 0.77 TOP2A (0.42) HDAC8HDAC1HDAC6ROCK2PRKG1
SCHEMBL6601241 0.76 MAPT (0.44) HDAC8HDAC1HDAC6MAPTMEN1
SCHEMBL7662221 0.76 CREBBP (0.44) CREBBPHDAC8HDAC1HDAC6MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1042296-B1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2004-02-25 EP claimed
US-6248754-B1 PSYCHOLOGICAL DISORDERS SMITHKLINE BEECHAM, P.L.C. (GB) 2001-06-19 US claimed
EP-1042296-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2000-10-11 EP claimed
WO-1999031068-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 1999-06-24 WO claimed
EP-1042296-B1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2004-02-25 EP disclosed
US-6248754-B1 PSYCHOLOGICAL DISORDERS SMITHKLINE BEECHAM, P.L.C. (GB) 2001-06-19 US disclosed
EP-1042296-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 2000-10-11 EP disclosed
WO-1999031068-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVES AND THEIR USE AS ANTICONVULSANTS SMITHKLINE BEECHAM PLC (GB) 1999-06-24 WO disclosed